Gravity Analytica

Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ALKS 01.02.2025

SERA-AI Powered Highlights

Date of Upcoming Event:2025-01-15

Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference

Full Press Release SEC Filings Our ALKS Tweets

About Gravity Analytica

Recent Filings

DUBLIN,Jan. 2, 2025/PRNewswire/ --Alkermes plc(Nasdaq: ALKS) announced today that its Chief Executive Officer,Richard Pops, will provide a corporate overview and update at the 43^rdAnnualJ.P. Morgan Healthcare Conference. The presentation will take place onWednesday, Jan. 15, 2025at11:15 a.m. PST(2:15 p.m. EST/7:15 p.m. GMT), followed by a question and answer session. The live webcast may be accessed under the Investors tab onwww.alkermes.comand will be archived for 14 days.

AboutAlkermes plcAlkermes plcis a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence,opioiddependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathichypersomnia. Headquartered inIreland,Alkermesalso has a corporate office and research and development center inMassachusettsand a manufacturing facility inOhio. For more information, please visitAlkermes' website atwww.alkermes.com.

Alkermes Contact:Jamie ConstantineInvestor Relations+1 781 873 2402

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302341496.html

SOURCEAlkermes plc

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com